EDGAR Filing Documents for 0001654954-19-006517

Form 8-K - Current report:

SEC Accession No. 0001654954-19-006517

Filing Date

2019-05-23

Accepted

2019-05-23 17:01:10

Documents

Period of Report

2019-05-23

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	azrx8k_20190523.htm	8-K	34035
2	PRESS RELEASE	ex99-1.htm	EX-99.1	17406
	Complete submission text file	0001654954-19-006517.txt		52614

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 19850962
SIC: 2834 Pharmaceutical Preparations